Nevada plans changes to seniors' Rx plan

3 May 2001

The Assembly of the US state of Nevada has passed legislative proposalsto change the current system of helping seniors to pay for prescription medication.

Under the current Senior RX program, which is run by insurance companies and financed with $5 million from a national tobacco settlement, seniors with the lowest incomes receive a $40 state subsidy towards the $74 monthly base cost of the plan. The new plan would use the same subsidy but the state would run the Senior RX plan, and it would also eliminate premiums for all seniors and reduce the co-pay for each prescription, reports the Associated Press. Assemblywoman Barbara Buckley, who sponsored the bill, has said that she is open to compromise.

Fewer than 300 residents have signed up for the Senior RX plan, proposed by the governor, since enrollment was opened last December; it is estimated that up to 11,000 Nevada seniors are eligible. In March, the state Senate passed a new proposal from the governor to do away with the premium for seniors with incomes below $12,700. The new plan is now in the Assembly.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight